XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 24, 2022
Operating Activities:    
Net income $ 747,509 $ 680,313
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 98,483 88,005
Amortization 33,751 34,349
Gain on sale or disposal of property and equipment (50) (1,652)
Unrealized foreign currency losses 9,927 45,498
Deferred income taxes (90,214) (101,133)
Stock compensation expense 66,214 57,871
Realized loss on marketable securities 56 982
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts (54,756) 156,666
Inventories 111,459 (442,312)
Other current and non-current assets 28,288 29,299
Accounts payable 55,340 (64,199)
Other current and non-current liabilities 430 (84,287)
Deferred revenue 7,063 (3,299)
Deferred costs (1,152) 3,426
Income Taxes (102,024) 20,067
Net cash provided by operating activities 910,324 419,594
Investing activities:    
Purchases of property and equipment (144,876) (184,928)
Proceeds from sale of property and equipment 157 1,693
Purchase of intangible assets (1,175) (1,411)
Purchase of marketable securities (116,039) (1,044,942)
Redemption of marketable securities 145,094 923,894
Acquisitions, net of cash acquired (150,853) (13,455)
Net cash used in investing activities (267,692) (319,149)
Financing activities:    
Dividends (419,166) (399,074)
Proceeds from issuance of treasury stock related to equity awards 21,946 41,052
Purchase of treasury stock related to equity awards (9,397) (14,750)
Purchase of treasury stock under share repurchase plan (79,533) (105,206)
Net cash used in financing activities (486,150) (477,978)
Effect of exchange rate changes on cash and cash equivalents (12,854) (38,265)
Net increase (decrease) in cash, cash equivalents, and restricted cash 143,628 (415,798)
Cash, cash equivalents, and restricted cash at beginning of period 1,279,912 1,498,843
Cash, cash equivalents, and restricted cash at end of period $ 1,423,540 $ 1,083,045